LNC Therapeutics

About:

LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.

Website: http://www.lnctherapeutics.com

Twitter/X: lnctherapeutics

Top Investors: Seventure Partners, AQUITI Gestion, IRDI, Blackstone Credit

Description:

LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of € 16.5 million raised so far including € 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases.